Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-25-000137

Director acquired 6,037 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Thornberry Nancy Director 2025-06-03 Grant or award +6,037 24,717 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Thornberry Nancy Director 2025-06-03 Grant or award · Stock Option (right to buy) +18,111 18,111 D: show line 2 in the form
Loading xslF345X05/wk-form4_1749154899.xml…